To mimic this genetic background in in vitro study, osteosarcoma HOS cells (R156P p53 mutation) [23] and MG-63 (mutant-p53, harboring a rearrangement in intron 1) [24,25] were used. This evidence concerns the gene TP53 and osteosarcoma.